Genelux Analyst Ratings
Guggenheim Initiates Genelux(GNLX.US) With Buy Rating, Announces Target Price $8
Maxim Group Maintains Genelux(GNLX.US) With Buy Rating, Announces Target Price $10
Promising Growth Potential and Clinical Advancements Drive Buy Rating for Genelux Corp.
Maxim Group Maintains Genelux(GNLX.US) With Buy Rating
Maxim Group Sticks to Their Buy Rating for Genelux Corp. (GNLX)
Genelux Analyst Ratings
Genelux Analyst Ratings
Genelux Analyst Ratings
Genelux Analyst Ratings
Buy Rating Affirmed for Genelux Corp on Strong Trial Progress and Solid Financials
Genelux Analyst Ratings
Genelux Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Genelux Corp. (GNLX), Adicet Bio (ACET) and Entera Bio (ENTX)
HC Wainwright & Co. Initiates Coverage On Genelux With Buy Rating, Announces Price Target of $35
Genelux Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Genelux Corp. (GNLX), Calliditas Therapeutics (CALT)
Genelux Analyst Ratings
Benchmark Company Adjusts Genelux Price Target to $30 From $38, Maintains Speculative Buy Rating
Genelux Analyst Ratings
No Data
No Data